{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:23:50Z","timestamp":1790900630163,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The incidence of breast cancer diagnosed during pregnancy is expected to increase as more women delay childbearing in the United States. Treatment of cancer in pregnant women requires prudent judgment to balance the benefit to the cancer patient and the risks to the fetus. Prospective data on the outcomes of children exposed to chemotherapy <jats:italic>in utero<\/jats:italic> are limited for the breast cancer population.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Between 1992 and 2010, 81 pregnant patients with breast cancer were treated in a single-arm, institutional review board\u2013approved study with 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) in the adjuvant or neoadjuvant setting. Labor and delivery records were reviewed for each patient and neonate. In addition, the parents or guardians were surveyed regarding the health outcomes of the children exposed to chemotherapy <jats:italic>in utero<\/jats:italic>.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>In total, 78% of the women (or next of kin) answered a follow-up survey. At a median age of 7 years, most of the children exposed to chemotherapy <jats:italic>in utero<\/jats:italic> were growing normally without any significant exposure-related toxicity or health problems. Three children were born with congenital abnormalities: one each with Down syndrome, ureteral reflux or clubfoot. The rate of congenital abnormalities in the cohort was similar to the national average of 3%.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>During the second and third trimesters, pregnant women with breast cancer can be treated with FAC safely without concerns for serious complications or short-term health concerns for their offspring who are exposed to chemotherapy <jats:italic>in utero<\/jats:italic>. Continued long-term follow-up of the children in this cohort is required.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Trial registration<\/jats:title>\n                        <jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/NCT00510367\">NCT00510367<\/jats:ext-link>. Other Study ID numbers: ID01-193, NCI-2012-01578. Registration date: 31 July 2007.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13058-014-0500-0","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T18:38:35Z","timestamp":1419878315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Outcomes of children exposed in uteroto chemotherapy for breast cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Rashmi K","family":"Murthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L","family":"Theriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad M","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildred M","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Milbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue A","family":"Rimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K","family":"Litton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"500_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0147-0272(83)80006-3","volume":"7","author":"MK Wallack","year":"1983","unstructured":"Wallack MK, Wolf JA, Bedwinek J, Denes AE, Glasgow G, Kumar B, Meyer JS, Rigg LA, Wilson-Krechel S: Gestational carcinoma of the female breast. Curr Probl Cancer. 1983, 7: 1-58. 10.1016\/S0147-0272(83)80006-3.","journal-title":"Curr Probl Cancer"},{"key":"500_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<751::AID-IJC1>3.0.CO;2-Q","volume":"67","author":"AE Lethaby","year":"1996","unstructured":"Lethaby AE, O\u2019Neill MA, Mason BH, Holdaway IM, Harvey VJ, the Auckland Breast Cancer Study Group: Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer. 1996, 67: 751-755. 10.1002\/(SICI)1097-0215(19960917)67:6<751::AID-IJC1>3.0.CO;2-Q.","journal-title":"Int J Cancer"},{"key":"500_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/AOG.0b013e3181b19154","volume":"114","author":"TM Andersson","year":"2009","unstructured":"Andersson TM, Johansson AL, Hsieh CC, Cnattingius S, Lambe M: Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009, 114: 568-572. 10.1097\/AOG.0b013e3181b19154.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"500_CR4","first-page":"1","volume":"60","author":"JA Martin","year":"2011","unstructured":"Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Kirmeyer S, Mathews TJ, Wilson EC: Births: final data for 2009. Natl Vital Stat Rep. 2011, 60 (1): 1-70.","journal-title":"Natl Vital Stat Rep"},{"key":"500_CR5","volume-title":"Delayed childbearing: more women are having their first child later in life","author":"TJ Matthews","year":"2009","unstructured":"Matthews TJ, Hamilton BE: Delayed childbearing: more women are having their first child later in life. 2009, National Center for Health Statistics, Hyattsville, MD"},{"key":"500_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02951421","volume":"9","author":"R Theriault","year":"2007","unstructured":"Theriault R, Hahn K: Management of breast cancer in pregnancy. Curr Oncol Rep. 2007, 9: 17-21. 10.1007\/BF02951421.","journal-title":"Curr Oncol Rep"},{"key":"500_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/jncimonographs\/lgi009","volume":"34","author":"K Gwyn","year":"2005","unstructured":"Gwyn K: Children exposed to chemotherapy in utero. J Natl Cancer Inst Monogr. 2005, 34: 69-71. 10.1093\/jncimonographs\/lgi009.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"500_CR8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cncr.11614","volume":"98","author":"LP Middleton","year":"2003","unstructured":"Middleton LP, Amin M, Gwyn K, Theriault R, Sashin A: Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer. 2003, 98: 1055-1060. 10.1002\/cncr.11614.","journal-title":"Cancer"},{"key":"500_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1634\/theoncologist.2010-0262","volume":"15","author":"JK Litton","year":"2010","unstructured":"Litton JK, Theriault RL: Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist. 2010, 15: 1238-1247. 10.1634\/theoncologist.2010-0262.","journal-title":"Oncologist"},{"key":"500_CR10","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1200\/JCO.2012.45.6335","volume":"31","author":"F Amant","year":"2013","unstructured":"Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, M\u00fcller V, Van Calsteren K, Rack B, Nekliludova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl: Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013, 31: 2532-2539. 10.1200\/JCO.2012.45.6335.","journal-title":"J Clin Oncol"},{"key":"500_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/cncr.24165","volume":"115","author":"BM Beadle","year":"2009","unstructured":"Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH: The impact of pregnancy on breast cancer outcomes in women \u226435 years. Cancer. 2009, 115: 1174-1184. 10.1002\/cncr.24165.","journal-title":"Cancer"},{"key":"500_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1634\/theoncologist.2012-0340","volume":"18","author":"JK Litton","year":"2013","unstructured":"Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH, Mittendorf EA, Barnett C, Gonzalez-Angulo AM, Hortob\u00e1gyi GN, Theriault RL: Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist. 2013, 18: 369-376. 10.1634\/theoncologist.2012-0340.","journal-title":"Oncologist"},{"key":"500_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1200\/JCO.1999.17.3.855","volume":"17","author":"DL Berry","year":"1999","unstructured":"Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN: Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999, 17: 855-861.","journal-title":"J Clin Oncol"},{"key":"500_CR14","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1200\/JCO.2005.03.038","volume":"23","author":"AE Ring","year":"2005","unstructured":"Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA: Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005, 23: 4192-4197. 10.1200\/JCO.2005.03.038.","journal-title":"J Clin Oncol"},{"key":"500_CR15","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics: Birth Defects: Data & Statistics. [http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/data.html] (accessed 5 January 2015)."},{"key":"500_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/PPO.0b013e3181ce46f9","volume":"16","author":"E Cardonick","year":"2010","unstructured":"Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A: Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010, 16: 76-82. 10.1097\/PPO.0b013e3181ce46f9.","journal-title":"Cancer J"},{"key":"500_CR17","first-page":"337","volume":"16","author":"DC Doll","year":"1989","unstructured":"Doll DC, Ringenberg QS, Yarbro JW: Antineoplastic agents and pregnancy. Semin Oncol. 1989, 16: 337-346.","journal-title":"Semin Oncol"},{"key":"500_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/cncr.22081","volume":"107","author":"KM Hahn","year":"2006","unstructured":"Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi , Theriault RL: Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006, 107: 1219-1226. 10.1002\/cncr.22081.","journal-title":"Cancer"},{"key":"500_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S1470-2045(12)70261-9","volume":"13","author":"S Loibl","year":"2012","unstructured":"Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, Fehm T, Van Calsteren K, Linn SC, Schlehe B, Gziri MM, Westenend PJ, M\u00fcller V, Heyns L, Rack B, Van Calster B, Harbeck N, Lenhard M, Halaska MJ, Kaufmann M, Nekljudova V, Amant F: Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012, 13: 887-896. 10.1016\/S1470-2045(12)70261-9.","journal-title":"Lancet Oncol"},{"key":"500_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/annonc\/mdp517","volume":"21","author":"O Mir","year":"2010","unstructured":"Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R: Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol. 2010, 21: 425-426. 10.1093\/annonc\/mdp517.","journal-title":"Ann Oncol"},{"key":"500_CR21","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/annonc\/mds170","volume":"23","author":"E Cardonick","year":"2012","unstructured":"Cardonick E, Bhat A, Gilmandyar D, Somer R: Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol. 2012, 23: 3016-3023. 10.1093\/annonc\/mds170.","journal-title":"Ann Oncol"},{"key":"500_CR22","unstructured":"Center for Disease Control and Prevention. National Center for Health Statistics. Vitalstats. http:\/\/www.cdc.gov\/nchs\/vitalstats.htm Accessed: 5\/25\/2011."},{"key":"500_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jsha.2010.03.005","volume":"22","author":"AA Lardhi","year":"2010","unstructured":"Lardhi AA: Prevalence and clinical significance of heart murmurs detected in routine neonatal examination. J Saudi Heart Assoc. 2010, 22: 25-27. 10.1016\/j.jsha.2010.03.005.","journal-title":"J Saudi Heart Assoc"},{"key":"500_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.survophthal.2004.12.005","volume":"50","author":"K Simons","year":"2005","unstructured":"Simons K: Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol. 2005, 50: 123-166. 10.1016\/j.survophthal.2004.12.005.","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 9","key":"500_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1528-1167.2005.00309.x","volume":"46","author":"P Jallon","year":"2005","unstructured":"Jallon P, Latour P: Epidemiology of idiopathic generalized epilepsies. Epilepsia. 2005, 46 (Suppl 9): 10-14. 10.1111\/j.1528-1167.2005.00309.x.","journal-title":"Epilepsia"},{"key":"500_CR26","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1542\/peds.99.3.e1","volume":"99","author":"BP Lanphear","year":"1997","unstructured":"Lanphear BP, Byrd RS, Auinger P, Hall CB: Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics. 1997, 99: E1-10.1542\/peds.99.3.e1.","journal-title":"Pediatrics"},{"key":"500_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/archpedi.154.2.150","volume":"154","author":"SP Nelson","year":"2000","unstructured":"Nelson SP, Chen EH, Syniar GM, Christoffel KK, the Pediatric Practice Research Group: Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Arch Pediatr Adolesc Med. 2000, 154: 150-154. 10.1001\/archpedi.154.2.150.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"500_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(11)70363-1","volume":"13","author":"F Amant","year":"2012","unstructured":"Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B, Wouters H, Heyns L, Han SN, Tomek V, Mertens L, Ottevanger PB: Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012, 13: 256-264. 10.1016\/S1470-2045(11)70363-1.","journal-title":"Lancet Oncol"},{"key":"500_CR29","unstructured":"National Toxicology Program, US Department of Health and Human Services: NTP Monograph: Developmental Effects and Pregnancy Outcomes Associated with Cancer Chemotherapy Use during Pregnancy. Research Triangle Park, NC: National Institute of Environmental Health Sciences; 13 May 2013."},{"key":"500_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","volume":"2","author":"A Av\u00edles","year":"2001","unstructured":"Av\u00edles A, Neri N: Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001, 2: 173-177. 10.3816\/CLM.2001.n.023.","journal-title":"Clin Lymphoma"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-014-0500-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0500-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:06:03Z","timestamp":1728921963000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-014-0500-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1186\/s13058-014-0500-0","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]},"assertion":[{"value":"15 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"500"}}